Literature DB >> 27986209

Prostate Cancer Genetics: Variation by Race, Ethnicity, and Geography.

Timothy R Rebbeck1.   

Abstract

Prostate cancer rates vary substantially by race, ethnicity, and geography. These disparities can be explained by variation in access to screening and treatment, variation in exposure to prostate cancer risk factors, and variation in the underlying biology of prostate carcinogenesis (including genomic propensity of some groups to develop biologically aggressive disease). It is clear that access to screening and access to treatment are critical influencing factors of prostate cancer rates; yet, even among geographically diverse populations with similar access to care (eg, low- and medium-income countries), African descent men have higher prostate cancer rates and poorer prognosis. To date, the proportion of prostate cancer that can be explained by environmental exposures is small, and the effect of these factors across different racial, ethnic, or geographical populations is poorly understood. In contrast, prostate cancer has one of the highest heritabilities of all major cancers. Numerous genetic susceptibility markers have been identified from family-based studies, candidate gene association studies, and genome-wide association studies. Some prostate cancer loci, including the risk loci found at chromosome 8q24, have consistent effects in all groups studied to date. However, replication of many susceptibility loci across race, ethnicity, and geography remains limited, and additional studies in certain populations (particularly in men of African descent) are needed to better understand the underlying genetic basis of prostate cancer.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27986209      PMCID: PMC5175208          DOI: 10.1016/j.semradonc.2016.08.002

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  78 in total

1.  Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men.

Authors:  Matthew L Freedman; Christopher A Haiman; Nick Patterson; Gavin J McDonald; Arti Tandon; Alicja Waliszewska; Kathryn Penney; Robert G Steen; Kristin Ardlie; Esther M John; Ingrid Oakley-Girvan; Alice S Whittemore; Kathleen A Cooney; Sue A Ingles; David Altshuler; Brian E Henderson; David Reich
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-31       Impact factor: 11.205

2.  Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.

Authors:  Zsofia Kote-Jarai; Ali Amin Al Olama; Graham G Giles; Gianluca Severi; Johanna Schleutker; Maren Weischer; Daniele Campa; Elio Riboli; Tim Key; Henrik Gronberg; David J Hunter; Peter Kraft; Michael J Thun; Sue Ingles; Stephen Chanock; Demetrius Albanes; Richard B Hayes; David E Neal; Freddie C Hamdy; Jenny L Donovan; Paul Pharoah; Fredrick Schumacher; Brian E Henderson; Janet L Stanford; Elaine A Ostrander; Karina Dalsgaard Sorensen; Thilo Dörk; Gerald Andriole; Joanne L Dickinson; Cezary Cybulski; Jan Lubinski; Amanda Spurdle; Judith A Clements; Suzanne Chambers; Joanne Aitken; R A Frank Gardiner; Stephen N Thibodeau; Dan Schaid; Esther M John; Christiane Maier; Walther Vogel; Kathleen A Cooney; Jong Y Park; Lisa Cannon-Albright; Hermann Brenner; Tomonori Habuchi; Hong-Wei Zhang; Yong-Jie Lu; Radka Kaneva; Ken Muir; Sara Benlloch; Daniel A Leongamornlert; Edward J Saunders; Malgorzata Tymrakiewicz; Nadiya Mahmud; Michelle Guy; Lynne T O'Brien; Rosemary A Wilkinson; Amanda L Hall; Emma J Sawyer; Tokhir Dadaev; Jonathan Morrison; David P Dearnaley; Alan Horwich; Robert A Huddart; Vincent S Khoo; Christopher C Parker; Nicholas Van As; Christopher J Woodhouse; Alan Thompson; Tim Christmas; Chris Ogden; Colin S Cooper; Aritaya Lophatonanon; Melissa C Southey; John L Hopper; Dallas R English; Tiina Wahlfors; Teuvo L J Tammela; Peter Klarskov; Børge G Nordestgaard; M Andreas Røder; Anne Tybjærg-Hansen; Stig E Bojesen; Ruth Travis; Federico Canzian; Rudolf Kaaks; Fredrik Wiklund; Markus Aly; Sara Lindstrom; W Ryan Diver; Susan Gapstur; Mariana C Stern; Roman Corral; Jarmo Virtamo; Angela Cox; Christopher A Haiman; Loic Le Marchand; Liesel Fitzgerald; Suzanne Kolb; Erika M Kwon; Danielle M Karyadi; Torben Falck Orntoft; Michael Borre; Andreas Meyer; Jürgen Serth; Meredith Yeager; Sonja I Berndt; James R Marthick; Briony Patterson; Dominika Wokolorczyk; Jyotsna Batra; Felicity Lose; Shannon K McDonnell; Amit D Joshi; Ahva Shahabi; Antje E Rinckleb; Ana Ray; Thomas A Sellers; Hui-Yi Lin; Robert A Stephenson; James Farnham; Heiko Muller; Dietrich Rothenbacher; Norihiko Tsuchiya; Shintaro Narita; Guang-Wen Cao; Chavdar Slavov; Vanio Mitev; Douglas F Easton; Rosalind A Eeles
Journal:  Nat Genet       Date:  2011-07-10       Impact factor: 38.330

3.  A comprehensive resequence-analysis of 250 kb region of 8q24.21 in men of African ancestry.

Authors:  Charles C Chung; Ann W Hsing; Richard Biritwum; Yao Tettey; Andrew Adjei; Michael B Cook; Angelo De Marzo; George Netto; Evelyn Tay; Joseph F Boland; Meredith Yeager; Stephen J Chanock
Journal:  Prostate       Date:  2014-05       Impact factor: 4.104

4.  Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.

Authors:  Julius Gudmundsson; Patrick Sulem; Andrei Manolescu; Laufey T Amundadottir; Daniel Gudbjartsson; Agnar Helgason; Thorunn Rafnar; Jon T Bergthorsson; Bjarni A Agnarsson; Adam Baker; Asgeir Sigurdsson; Kristrun R Benediktsdottir; Margret Jakobsdottir; Jianfeng Xu; Thorarinn Blondal; Jelena Kostic; Jielin Sun; Shyamali Ghosh; Simon N Stacey; Magali Mouy; Jona Saemundsdottir; Valgerdur M Backman; Kristleifur Kristjansson; Alejandro Tres; Alan W Partin; Marjo T Albers-Akkers; Javier Godino-Ivan Marcos; Patrick C Walsh; Dorine W Swinkels; Sebastian Navarrete; Sarah D Isaacs; Katja K Aben; Theresa Graif; John Cashy; Manuel Ruiz-Echarri; Kathleen E Wiley; Brian K Suarez; J Alfred Witjes; Mike Frigge; Carole Ober; Eirikur Jonsson; Gudmundur V Einarsson; Jose I Mayordomo; Lambertus A Kiemeney; William B Isaacs; William J Catalona; Rosa B Barkardottir; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2007-04-01       Impact factor: 38.330

5.  Replication of prostate cancer risk loci on 8q24, 11q13, 17q12, 19q33, and Xp11 in African Americans.

Authors:  Stanley Hooker; Wenndy Hernandez; Hankui Chen; Christiane Robbins; Jada Benn Torres; Chiledum Ahaghotu; John Carpten; Rick A Kittles
Journal:  Prostate       Date:  2010-02-15       Impact factor: 4.104

Review 6.  Site-specific familial aggregation of prostate cancer.

Authors:  Bas A J Verhage; Katja K H Aben; J Alfred Witjes; Huub Straatman; Jack A Schalken; Lambertus A L M Kiemeney
Journal:  Int J Cancer       Date:  2004-04-20       Impact factor: 7.396

7.  TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion.

Authors:  Sven Perner; Juan-Miguel Mosquera; Francesca Demichelis; Matthias D Hofer; Pamela L Paris; Jeff Simko; Colin Collins; Tarek A Bismar; Arul M Chinnaiyan; Angelo M De Marzo; Mark A Rubin
Journal:  Am J Surg Pathol       Date:  2007-06       Impact factor: 6.394

8.  Prostate Cancer Susceptibility in Men of African Ancestry at 8q24.

Authors:  Ying Han; Kristin A Rand; Dennis J Hazelett; Sue A Ingles; Rick A Kittles; Sara S Strom; Benjamin A Rybicki; Barbara Nemesure; William B Isaacs; Janet L Stanford; Wei Zheng; Fredrick R Schumacher; Sonja I Berndt; Zhaoming Wang; Jianfeng Xu; Nadin Rohland; David Reich; Arti Tandon; Bogdan Pasaniuc; Alex Allen; Dominique Quinque; Swapan Mallick; Dimple Notani; Michael G Rosenfeld; Ranveer Singh Jayani; Suzanne Kolb; Susan M Gapstur; Victoria L Stevens; Curtis A Pettaway; Edward D Yeboah; Yao Tettey; Richard B Biritwum; Andrew A Adjei; Evelyn Tay; Ann Truelove; Shelley Niwa; Anand P Chokkalingam; Esther M John; Adam B Murphy; Lisa B Signorello; John Carpten; M Cristina Leske; Suh-Yuh Wu; Anslem J M Hennis; Christine Neslund-Dudas; Ann W Hsing; Lisa Chu; Phyllis J Goodman; Eric A Klein; S Lilly Zheng; John S Witte; Graham Casey; Alex Lubwama; Loreall C Pooler; Xin Sheng; Gerhard A Coetzee; Michael B Cook; Stephen J Chanock; Daniel O Stram; Stephen Watya; William J Blot; David V Conti; Brian E Henderson; Christopher A Haiman
Journal:  J Natl Cancer Inst       Date:  2016-01-27       Impact factor: 13.506

9.  Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women.

Authors:  Myrto Barrdahl; Federico Canzian; Amit D Joshi; Ruth C Travis; Jenny Chang-Claude; Paul L Auer; Susan M Gapstur; Mia Gaudet; W Ryan Diver; Brian E Henderson; Christopher A Haiman; Fredrick R Schumacher; Loïc Le Marchand; Christine D Berg; Stephen J Chanock; Robert N Hoover; Anja Rudolph; Regina G Ziegler; Graham G Giles; Laura Baglietto; Gianluca Severi; Susan E Hankinson; Sara Lindström; Walter Willet; David J Hunter; Julie E Buring; I-Min Lee; Shumin Zhang; Laure Dossus; David G Cox; Kay-Tee Khaw; Eiliv Lund; Alessio Naccarati; Petra H Peeters; J Ramón Quirós; Elio Riboli; Malin Sund; Dimitrios Trichopoulos; Ross L Prentice; Peter Kraft; Rudolf Kaaks; Daniele Campa
Journal:  Hum Mol Genet       Date:  2014-05-08       Impact factor: 6.150

10.  Genome-wide association scan for variants associated with early-onset prostate cancer.

Authors:  Ethan M Lange; Anna M Johnson; Yunfei Wang; Kimberly A Zuhlke; Yurong Lu; Jessica V Ribado; Gregory R Keele; Jin Li; Qing Duan; Ge Li; Zhengrong Gao; Yun Li; Jianfeng Xu; William B Isaacs; Siqun Zheng; Kathleen A Cooney
Journal:  PLoS One       Date:  2014-04-16       Impact factor: 3.240

View more
  72 in total

Review 1.  [Familial prostate cancer and genetic predisposition].

Authors:  V H Meissner; M Jahnen; K Herkommer
Journal:  Urologe A       Date:  2021-03-15       Impact factor: 0.639

2.  Use of empiric methods to inform prostate cancer health disparities: Comparison of neighborhood-wide association study "hits" in black and white men.

Authors:  Shannon M Lynch; Kristen Sorice; Erin K Tagai; Elizabeth A Handorf
Journal:  Cancer       Date:  2020-02-03       Impact factor: 6.860

Review 3.  The changing landscape of cancer in the USA - opportunities for advancing prevention and treatment.

Authors:  Farhad Islami; Rebecca L Siegel; Ahmedin Jemal
Journal:  Nat Rev Clin Oncol       Date:  2020-05-28       Impact factor: 66.675

4.  Predictors of prostate bed recurrence on magnetic resonance imaging in patients with rising prostate-specific antigen after radical prostatectomy.

Authors:  Nicola J Nasser; Victoria Chernyak; Viswanathan Shankar; Madhur Garg; William Bodner; Shalom Kalnicki; Jonathan Klein
Journal:  Can Urol Assoc J       Date:  2021-01       Impact factor: 1.862

5.  Evaluation of neutrophil-to-lymphocyte ratio as a prognostic indicator in a Singapore cohort of patients with clinically localized prostate cancer treated with prostatectomy.

Authors:  Yadong Lu; Hong Hong Huang; Weber Kam On Lau
Journal:  World J Urol       Date:  2019-04-05       Impact factor: 4.226

6.  MiR-1273 g-3p Promotes Malignant Progression and has Prognostic Implications in Prostate Cancer.

Authors:  Yaxue Chang; Qian Deng; Zhenfeng Guan; Yongyi Cheng; Yi Sun
Journal:  Mol Biotechnol       Date:  2021-08-24       Impact factor: 2.695

Review 7.  Impact of Gene-Environment Interactions on Cancer Development.

Authors:  Ariane Mbemi; Sunali Khanna; Sylvianne Njiki; Clement G Yedjou; Paul B Tchounwou
Journal:  Int J Environ Res Public Health       Date:  2020-11-03       Impact factor: 3.390

8.  A Custom Genotyping Array Reveals Population-Level Heterogeneity for the Genetic Risks of Prostate Cancer and Other Cancers in Africa.

Authors:  Maxine Harlemon; Olabode Ajayi; Paidamoyo Kachambwa; Michelle S Kim; Corinne N Simonti; Melanie H Quiver; Desiree C Petersen; Anuradha Mittal; Pedro W Fernandez; Ann W Hsing; Shakuntala Baichoo; Ilir Agalliu; Mohamed Jalloh; Serigne M Gueye; Nana Yaa F Snyper; Ben Adusei; James E Mensah; Afua O D Abrahams; Akindele O Adebiyi; Akin T Orunmuyi; Oseremen I Aisuodionoe-Shadrach; Maxwell M Nwegbu; Maureen Joffe; Wenlong C Chen; Hayley Irusen; Alfred I Neugut; Yuri Quintana; Moleboheng Seutloali; Mayowa B Fadipe; Christopher Warren; Marcos H Woehrmann; Peng Zhang; Chrissie M Ongaco; Michelle Mawhinney; Jo McBride; Caroline V Andrews; Marcia Adams; Elizabeth Pugh; Timothy R Rebbeck; Lindsay N Petersen; Joseph Lachance
Journal:  Cancer Res       Date:  2020-05-11       Impact factor: 12.701

9.  Sequencing at lymphoid neoplasm susceptibility loci maps six myeloma risk genes.

Authors:  Rosalie Griffin Waller; Robert J Klein; Joseph Vijai; James D McKay; Alyssa Clay-Gilmour; Xiaomu Wei; Michael J Madsen; Douglas W Sborov; Karen Curtin; Susan L Slager; Kenneth Offit; Celine M Vachon; Steven M Lipkin; Charles Dumontet; Nicola J Camp
Journal:  Hum Mol Genet       Date:  2021-06-09       Impact factor: 6.150

10.  The role of caveolin-1 and endothelial nitric oxide synthase polymorphisms in susceptibility to prostate cancer.

Authors:  Mahdieh Aliyari; Daniel Elieh Ali Komi; Amir Kiani; Mahmoudreza Moradi; Maryam Tanhapour; Zohreh Rahimi; Hadi Mozafari; Ehsan Mohammadi-Noori; Tayebeh Pourmotabbed; Asad Vaisi-Raygani; Fariborz Bahrehmand
Journal:  Int J Exp Pathol       Date:  2021-05-08       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.